Ecnoglutide

FDA-approved GLP-1 medications and their generic active ingredients.

Definition

Sciwind Biosciences' biased GLP-1 receptor agonist (licensed to Pfizer for China). Phase 3 SLIMMER trial reported positive results in Lancet Diabetes Endocrinology 2025. Approved by China's NMPA. Not FDA-approved and not in active US development.

GLP-1 pipeline: survodutide, MariTide, ecnoglutide →

Definition curated by Weight Loss Rankings — sourced from FDA labels and peer-reviewed PubMed literature, never AI-generated summaries.

Related terms in Drugs and brands

Wegovy
Ozempic
Rybelsus
Saxenda
Zepbound
Mounjaro
Foundayo
Semaglutide
Tirzepatide
Orforglipron
Retatrutide
CagriSema
Cagrilintide
Survodutide
MariTide (Maridebart Cafraglutide)

Looking for more depth?

GLP-1 pipeline: survodutide, MariTide, ecnoglutide
Browse the full GLP-1 glossary (51 terms across 8 categories)
Research articles — primary-source deep dives
Tools and calculators
Compare GLP-1 telehealth providers